Close
日本語
School of Medicine Faculty of Medicine Clinical Pharmacology & Therapeutics
Assistant Professor
龍口　万里子
TATSUGUCHI Mariko

Last updated： 2026/04/29
Basic information on teaching staff
Career
1994/4/- 1996/3/ 東京女子医科大学
1996/4/- 2002/3/ 東京女子医科大学
2000/4/- 2002/3/ 東京女子医科大学
2002/4/- 2005/3/ University of Arizona
2005/4/- 2009/7/ University North Carolina
2009/8/- 2011/3/ Harvard University
2012/5/- 2013/12/ 静岡徳州会病院
2014/1/- 2017/3/ 榛原総合病院
2017/4/- 2019/3/ 聖隷三方原病院
2019/4/- 浜松医科大学
Academic background
1994/3/ graduated 東京女子医科大学
2000/3/ completed 東京女子医科大学大学院
Research Areas
Life Science - Clinical pharmacy
Life Science - Cardiology
Life Science - Respiratory medicine
Research activities
Research presentations
[1]. 2025/12/5 An Investigation into the Effectiveness of Empathetic Communication in Informed Consent for Clinical Research Participation Among Medical Students 第46回日本臨床薬理学会学術総会
[2]. 2024/12/14 Bayesian estimation of plasma drug concentrations in children and adult patients with pulmonary arterial hypertension 第45回日本臨床薬理学会学術総会
[3]. 2024/12/14 Pharmacokinetics of edoxaban before and after balloon pulmonary arterioplasty in three cases of chronic thromboembolic pulmonary hypertension. 第45回日本臨床薬理学会学術総会
[4]. 2024/6/29 Pharmacokinetics of riociguat before and after balloon pulmonary arterioplasty in 9 cases of chronic thromboembolic pulmonary hypertension. The Seventh World Symposium on Pulmonary Hypertension
[5]. 2023/12/16 armacokinetics of riociguat before and after balloon pulmonary arterioplasty in 9 cases of chronic thromboembolic pulmonary hypertension. 第44回日本臨床薬理学会学術総会
5/8 View details...
Educational activities
Allotted class
[1]. Clinical Pharmacological Approach to Cardiovascular Disease
Social activities
Social Contribution
[1]. 2023/3/29- 2025/8/25 Phase III, non-randomized, uncontrolled, open-label study to evaluate the efficacy and safety of MK-7962 (Sotatercept) when given as an add-on to basal therapy in Japanese patients with pulmonary arterial hypertension